We are live on ! Find out more
VA

Vident Advisory Portfolio holdings

AUM $11.7B
1-Year Est. Return 37.32%
This Fund
S&P 500
This Quarter Est. Return
+4.06%
1 Year Est. Return
+37.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$3.62B
AUM Growth
-$1.18B
Cap. Flow
-$1.18B
Cap. Flow %
-32.7%
Top 10 Hldgs %
16.49%
Holding
1,533
New
211
Increased
794
Reduced
387
Closed
126

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$52.4M
2
JNJ icon
Johnson & Johnson
JNJ
+$39.1M
3
TMUS icon
T-Mobile US
TMUS
+$37.2M
4
ABBV icon
AbbVie
ABBV
+$35.8M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$34.6M

Sector Composition

Rank Sector Weight
1 Technology 29.28%
2 Financials 10.77%
3 Consumer Discretionary 8.99%
4 Industrials 8.73%
5 Healthcare 6.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ANET icon
101
Arista Networks
ANET
$219B
$7.11M 0.2%
81,128
+7,944
+11% +$591K
BKR icon
102
Baker Hughes
BKR
$56.8B
$7.1M 0.2%
201,923
+189,717
+1,554% +$6.22M
BTDR icon
103
Bitdeer Technologies
BTDR
$2.81B
$7.08M 0.2%
689,997
-178,625
-21% -$1.22M
BMY icon
104
Bristol-Myers Squibb
BMY
$127B
$7.04M 0.19%
169,464
-605,522
-78% -$27.1M
OKTA icon
105
Okta
OKTA
$24.1B
$7M 0.19%
74,765
+18,336
+32% +$1.74M
KEEL
106
Keel Infrastructure Corp
KEEL
$2.57B
$6.96M 0.19%
2,706,960
+99,990
+4% +$215K
EOG icon
107
EOG Resources
EOG
$78B
$6.94M 0.19%
55,126
+2,142
+4% +$275K
QCOM icon
108
Qualcomm
QCOM
$176B
$6.92M 0.19%
34,756
-149,658
-81% -$28.3M
RIOT icon
109
Riot Platforms
RIOT
$8.52B
$6.9M 0.19%
754,836
+256,635
+52% +$2.59M
VXF icon
110
Vanguard Extended Market ETF
VXF
$30.3B
$6.62M 0.18%
39,214
+3,159
+9% +$533K
ZTS icon
111
Zoetis
ZTS
$31.6B
$6.59M 0.18%
38,014
-499
-1% -$83K
ACN icon
112
Accenture
ACN
$89.9B
$6.57M 0.18%
21,643
+10,080
+87% +$3.09M
PLD icon
113
Prologis
PLD
$138B
$6.53M 0.18%
58,144
-22,136
-28% -$2.45M
VCIT icon
114
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
$66.1B
$6.52M 0.18%
+81,567
New +$6.48M
AKAM icon
115
Akamai
AKAM
$16.8B
$6.46M 0.18%
71,734
+21,811
+44% +$2.11M
QLYS icon
116
Qualys
QLYS
$4.84B
$6.2M 0.17%
43,467
+15,725
+57% +$2.39M
REGN icon
117
Regeneron Pharmaceuticals
REGN
$68.8B
$6.17M 0.17%
5,872
-18,860
-76% -$18.3M
WMT icon
118
Walmart Inc
WMT
$871B
$6.15M 0.17%
90,817
+5,427
+6% +$342K
CYBR
119
DELISTED
CyberArk
CYBR
$6.09M 0.17%
22,285
-37,295
-63% -$9.16M
CORT icon
120
Corcept Therapeutics
CORT
$10.2B
$6.04M 0.17%
186,020
+3,601
+2% +$98.6K
DLR icon
121
Digital Realty Trust
DLR
$73.7B
$5.95M 0.16%
39,148
-36,255
-48% -$5.21M
VST icon
122
Vistra
VST
$55.1B
$5.92M 0.16%
68,835
+6,826
+11% +$571K
QQQ icon
123
Invesco QQQ Trust
QQQ
$455B
$5.86M 0.16%
12,230
-5,885
-32% -$2.65M
MAR icon
124
Marriott International
MAR
$98.7B
$5.77M 0.16%
23,852
+406
+2% +$97.5K
AOS icon
125
A.O. Smith
AOS
$8.38B
$5.75M 0.16%
70,317
-105,820
-60% -$8.96M

Similar funds

Vident Advisory's Q2 2024 Portfolio in Review

As of Q2 2024, Vident Advisory held 1,533 positions worth $3.62B, down 25% from $4.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Vident Advisory withdrew a net $1.18B in Q2 2024, closing 126 positions and reducing 387 holdings. Its most notable exit was Enterprise Products Partners, an estimated $20M position sold in full.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, Vident Advisory opened a new position in Vanguard Intermediate-Term Treasury ETF worth $19M.

  • Vident Advisory's largest Q2 2024 buy was Vanguard Intermediate-Term Treasury ETF: 326,646 shares worth $19M.
  • Vident Advisory added most to Tesla in Q2 2024, an estimated $29.1M increase.
  • Vident Advisory's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $52.4M.
  • Vident Advisory fully exited Enterprise Products Partners in Q2 2024, selling an estimated $20M.
  • Vident Advisory's ten largest holdings make up 16% of its $3.62B portfolio in Q2 2024.
  • Vident Advisory opened 211 new positions and closed 126 in Q2 2024.
  • Vident Advisory's portfolio value fell 25% quarter-over-quarter to $3.62B.

Based on Vident Advisory's 13F filing for Q2 2024, filed 14 Aug 2024.